The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Inflammation significantly contributes to the progression of chronic kidney disease (CKD). Inflammasome-dependent cytokines, such as IL-1β and IL-18, play a role in CKD, but their regulation during renal injury is unknown. Here, we analyzed the processing of caspase-1, IL-1β, and IL-18 after unilateral ureteral obstruction (UUO) in mice, which suggested activation of the Nlrp3 inflammasome during renal injury. Compared with wild-type mice, Nlrp3(-/-) mice had less tubular injury, inflammation, and fibrosis after UUO, associated with a reduction in caspase-1 activation and maturation of IL-1β and IL-18; these data confirm that the Nlrp3 inflammasome upregulates these cytokines in the kidney during injury. Bone marrow chimeras revealed that Nlrp3 mediates the injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments. In tissue from human renal biopsies, a wide variety of nondiabetic kidney diseases exhibited increased expression of NLRP3 mRNA, which correlated with renal function. Taken together, these results strongly support a role for NLRP3 in renal injury and identify the inflammasome as a possible therapeutic target in the treatment of patients with progressive CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
“These studies strongly support a crucial role for NLRP3 inflammasome involvement in the progression of ischemic kidney injury and CKD. Efforts in our laboratory have focused on understanding the molecular pathogenesis of glomerular injury related to elevated Hcys, which, if left unattended, has the potential to progres…”
InfluentialInflammatory processes in renal fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.114 · Cited by 690
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Mihai, S., Codrici, E., Popescu, I. D., Enciu, A.-M., Albulescu, L., Necula, L. G., Mambet, C., Anton, G., & Tanase, C. (2018) · Journal of Immunology Research · doi:10.1155/2018/2180373 · Cited by 673
“concluded that inflammasomedependent cytokines IL-1β and IL-18 were upregulated in association with caspase-1 activation; compared with wildtype mice, NLRP3 mice expressed less tubular injury, inflammation, and fibrosis after UUO, which highlighted the activation of NLRP3 inflammasome [45].”
BackgroundSterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Host Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Innate immunity in diabetic kidney disease
Tang, S. C. W., & Yiu, W. H. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0234-4 · Cited by 596
Reactive oxygen species at the crossroads of inflammasome and inflammation
Harijith, A., Ebenezer, D. L., & Natarajan, V. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00352 · Cited by 476
“Local IL-1α secretion participates in the onset of kidney inflammation (Vilaysane et al., 2010).”
BackgroundCalcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion
Mulay, S. R., Kulkarni, O. P., Rupanagudi, K. V., Migliorini, A., Darisipudi, M. N., Vilaysane, A., Muruve, D., Shi, Y., Munro, F., Liapis, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63679 · Cited by 468
“TECs express NLRP3 but lack pro–IL-1 β induction upon NF-κ B priming (26, 38, 39).”
Self-citationA 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
Barnett, K. C., Li, S., Liang, K., & Ting, J. P.-Y. (2023) · Cell · doi:10.1016/j.cell.2023.04.025 · Cited by 458
Lin, Q., Li, S., Jiang, N., Jin, H., Shao, X., Zhu, X., Wu, J., Zhang, M., Zhang, Z., Shen, J., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1848971 · Cited by 391
The Inflammasomes in Kidney Disease
Anders, H.-J., & Muruve, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080798 · Cited by 351
Self-citationAnders, H.-J., & Schaefer, L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010117 · Cited by 330
The Role of Inflammation in CKD
Kadatane, S. P., Satariano, M., Massey, M., Mongan, K., & Raina, R. (2023) · Cells · doi:10.3390/cells12121581 · Cited by 322
“One study reported a reduction in tubular injury, inflammation and fibrosis after UUO (unilateral urethral obstruction), associated with a reduction in caspase-1 activation and maturation of IL-1β and IL-18 in NLRP3−/− mice [34].”
BackgroundThe role of inflammasomes in kidney disease
Komada, T., & Muruve, D. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0158-z · Cited by 304
Self-citationMacrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice
Monnerat, G., Alarcón, M. L., Vasconcellos, L. R., Hochman-Mendez, C., Brasil, G., Bassani, R. A., Casis, O., Malan, D., Travassos, L. H., Sepúlveda, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13344 · Cited by 279
Adenine‐induced chronic kidney disease in rats
Diwan, V., Brown, L., & Gobe, G. C. (2018) · Nephrology · doi:10.1111/nep.13180 · Cited by 273
“Increased NLRP-3 expression was associated with progressive kidney disease.(45) Uric acid may contribute to the pathogenesis of inflammatory diseases(46) by inducing NLRP-3.”
BackgroundTsai, P.-Y., Ka, S.-M., Chang, J.-M., Chen, H.-C., Shui, H.-A., Li, C.-Y., Hua, K.-F., Chang, W.-L., Huang, J.-J., Yang, S.-S., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.016 · Cited by 266
Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease
Anders, H.-J. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020177 · Cited by 250
Targeting innate immunity-driven inflammation in CKD and cardiovascular disease
Speer, T., Dimmeler, S., Schunk, S. J., Fliser, D., & Ridker, P. M. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00621-9 · Cited by 232
Macrophage Phenotype and Fibrosis in Diabetic Nephropathy
Calle, P., & Hotter, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082806 · Cited by 249
“NLRP3 is involved in chronic kidney disease pathogenesis [90,91].”
BackgroundInflammasome-Independent NLRP3 Augments TGF-β Signaling in Kidney Epithelium
Wang, W., Wang, X., Chun, J., Vilaysane, A., Clark, S., French, G., Bracey, N. A., Trpkov, K., Bonni, S., Duff, H. J., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201959 · Cited by 241
“NLRP3 and inflammasome gene expression in kidney epithelial cells We previously demonstrated reduced tubular injury and renal fibrosis in Nlrp32/2 mice undergoing unilateral ureteric obstruction (UUO), a model of chronic kidney injury (15).”
BackgroundResultSelf-citationZhang, K., Fan, C., Cai, D., Zhang, Y., Zuo, R., Zhu, L., Cao, Y., Zhang, J., Liu, C., Chen, Y., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00001 · Cited by 243
The NLRP3 inflammasome in kidney disease and autoimmunity
Hutton, H. L., Ooi, J. D., Holdsworth, S. R., & Kitching, A. R. (2016) · Nephrology · doi:10.1111/nep.12785 · Cited by 234
“© 2016 Asian Pacific Society of Nephrology738 Experimental IRI highlights the role of IL-1 in initiating an inflammatory cascade, resulting in the recruitment of neutrophils and macrophages to the kidney.28,30 IL-18 is a keymediator in IRI, with caspase 1-deficientmice,mice treated with IL-18 blocking antibodies and I…”
BackgroundThe Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
The role of the NLRP3 inflammasome in gout
McDermott, M., Kingsbury, S., & Conaghan (2011) · Journal of Inflammation Research · doi:10.2147/jir.s11330 · Cited by 219
Wang, C., Pan, Y., Zhang, Q.-Y., Wang, F.-M., & Kong, L.-D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038285 · Cited by 232
“The activated caspase-1 contributes to the maturation of IL-1b and IL-18 [13,14].”
BackgroundInfluentialNALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy
Knauf, F., Asplin, J. R., Granja, I., Schmidt, I. M., Moeckel, G. W., David, R. J., Flavell, R. A., & Aronson, P. S. (2013) · Kidney International · doi:10.1038/ki.2013.207 · Cited by 231
Crystal nephropathies: mechanisms of crystal-induced kidney injury
Mulay, S. R., & Anders, H.-J. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.10 · Cited by 219
Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets
De Miguel, C., Rudemiller, N. P., Abais, J. M., & Mattson, D. L. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0507-z · Cited by 215
Acute Kidney Injury in Older Adults
Anderson, S., Eldadah, B., Halter, J. B., Hazzard, W. R., Himmelfarb, J., Horne, F. M., Kimmel, P. L., Molitoris, B. A., Murthy, M., O'Hare, A. M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090934 · Cited by 217
Liu, H., Doke, T., Guo, D., Sheng, X., Ma, Z., Park, J., Vy, H. M. T., Nadkarni, G. N., Abedini, A., Miao, Z., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01097-w · Cited by 209
Kramann, R., DiRocco, D. P., & Humphreys, B. D. (2013) · The Journal of Pathology · doi:10.1002/path.4253 · Cited by 211
GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy
Li, Y., Yuan, Y., Huang, Z.-X., Chen, H., Lan, R., Wang, Z., Lai, K., Chen, H., Chen, Z., Zou, Z., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00755-6 · Cited by 207
Self-citationDieudé, M., Bell, C., Turgeon, J., Beillevaire, D., Pomerleau, L., Yang, B., Hamelin, K., Qi, S., Pallet, N., Béland, C., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9816 · Cited by 202
“Human proximal tubular epithelial cells (HPTC) were isolated as previously described from nondiseased nephrectomy samples from patients with renal cell carcinoma (69).”
MethodSelf-citationTang, T.-T., Lv, L.-L., Pan, M.-M., Wen, Y., Wang, B., Li, Z.-L., Wu, M., Wang, F.-M., Crowley, S. D., & Liu, B.-C. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0378-3 · Cited by 212
RIPK3-Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival
Lau, A., Wang, S., Jiang, J., Haig, A., Pavlosky, A., Linkermann, A., Zhang, Z.-X., & Jevnikar, A. M. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12447 · Cited by 204
“Necrosis promotes inflammatory injury in kidneys (15,16) as membrane rupture results in the release of pro-inflammatory endogenous molecules including heat-shock proteins, unprocessed high-mobility group box 1 (HMGB1), uric acid, fibronectin, IL-33 and others (17,18).”
BackgroundCanonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis
Lorenz, G., Darisipudi, M. N., & Anders, H.-J. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft332 · Cited by 207
Kim, S.-M., Lee, S.-H., Kim, Y.-G., Kim, S.-Y., Seo, J.-W., Choi, Y.-W., Kim, D.-J., Jeong, K.-H., Lee, T.-W., Ihm, C.-G., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00637.2014 · Cited by 204
“Other recent reports have suggested that NLRP3 is expressed in podocytes secreting IL-1 and that its expression promotes podocyte injury under hyperhomocysteinemia (37, 39).”
BackgroundVajjhala, P. R., Mirams, R. E., & Hill, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381228 · Cited by 193
TGF-Beta as a Master Regulator of Diabetic Nephropathy
Wang, L., Wang, H.-L., Liu, T.-T., & Lan, H.-Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157881 · Cited by 185
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Chen, K., Zhang, J., Zhang, W., Zhang, J., Yang, J., Li, K., & He, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.009 · Cited by 197
“NLRP3 knock-out mice are protected from renal tubule damge and renal interstitial inflammation in kidney unilateral ureteral cclusion (UUO) and ischemia–reperfusion models (Shigeoka et al., 010; Vilaysane et al., 2010).”
BackgroundNLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice
Wu, M., Han, W., Song, S., Du, Y., Liu, C., Chen, N., Wu, H., Shi, Y., & Duan, H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.08.002 · Cited by 197
An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
Ludwig-Portugall, I., Bartok, E., Dhana, E., Evers, B. D. G., Primiano, M. J., Hall, J. P., Franklin, B. S., Knolle, P. A., Hornung, V., Hartmann, G., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.035 · Cited by 193
Bracey, N. A., Beck, P. L., Muruve, D. A., Hirota, S. A., Guo, J., Jabagi, H., Wright Jr, J. R., MacDonald, J. A., Lees‐Miller, J. P., Roach, D., et al. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.068338 · Cited by 188
“…the 31 kDa precursor cytokine prointerleukin-1β (pro-IL-1β) into the 17 kDa mature form, which participates in the pathogenesis of a range of chronic diseases such as diabetes, kidney injury and gouty arthritis (Martinon et al. 2006; Hirota et al. 2010; Schroder et al. 2010; Vilaysane et al. 2010).”
BackgroundMethodInfluentialSelf-citationGasdermins and pyroptosis in the kidney
Elias, E. E., Lyons, B., & Muruve, D. A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00662-0 · Cited by 193
Self-citationZhang, C., Boini, K. M., Xia, M., Abais, J. M., Li, X., Liu, Q., & Li, P.-L. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.189688 · Cited by 188
“In this regard, although a recent study reported that ASC knockout mice did not protect the kidney from ischemiareperfusion injury,(28) NALP3 knockout mice had less interstitial fibrosis as compared with their wide-type littermates.(26) These observations, together with our findings in the hHcys mouse model, point to…”
BackgroundSalt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension
Chakraborty, S., Galla, S., Cheng, X., Yeo, J.-Y., Mell, B., Singh, V., Yeoh, B., Saha, P., Mathew, A. V., Vijay-Kumar, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.058 · Cited by 176
“Previous reports suggest a role for Nlrp3 in renal injury and identify the Nlrp3 inflammasome as a possible therapeutic target in the treatment of patients with progressive chronic kidney disease (Anders et al., 2018; Bai et al., 2017; Bugyei-Twum et al., 2016; Foresto-Neto et al., 2018; Hutton et al., 2016; Vilaysane…”
BackgroundPattern recognition receptors and the inflammasome in kidney disease
Leemans, J. C., Kors, L., Anders, H.-J., & Florquin, S. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.91 · Cited by 175
Liu, J., Zhou, J., Luan, Y., Li, X., Meng, X., Liao, W., Tang, J., & Wang, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01466-w · Cited by 193
Hu, Q.-H., Zhang, X., Pan, Y., Li, Y.-C., & Kong, L.-D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.03.005 · Cited by 171
“005 renal disease, indicating that the NLRP3 inflammasome promotes renal inflammation and contributes to chronic kidney disease [7].”
BackgroundSelf-citationTang, T.-T., Lv, L.-L., Wang, B., Cao, J.-Y., Feng, Y., Li, Z.-L., Wu, M., Wang, F.-M., Wen, Y., Zhou, L.-T., et al. (2019) · Theranostics · doi:10.7150/thno.33520 · Cited by 163
“The NLRP3/caspase-1 axis, which propagates renal inflammation [42-44], cleaves cellular GR and diminishes cell sensitivity to glucocorticoids [45].”
BackgroundSzeto, H. H., Liu, S., Soong, Y., Seshan, S. V., Cohen-Gould, L., Manichev, V., Feldman, L. C., & Gustafsson, T. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070761 · Cited by 170
Chi, H.-H., Hua, K.-F., Lin, Y.-C., Chu, C.-L., Hsieh, C.-Y., Hsu, Y.-J., Ka, S.-M., Tsai, Y.-L., Liu, F.-C., & Chen, A. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016080840 · Cited by 168
Evolving concepts in the pathogenesis of uraemic cardiomyopathy
Wang, X., & Shapiro, J. I. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0101-8 · Cited by 161
Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis
Nørregaard, R., Mutsaers, H. A. M., Frøkiær, J., & Kwon, T. (2023) · Physiological Reviews · doi:10.1152/physrev.00027.2022 · Cited by 178
“During that time, they also observed increased levels of activated caspase-1 and mature IL-1 b and IL-18 (340).”
BackgroundInfluentialBracey, N. A., Gershkovich, B., Chun, J., Vilaysane, A., Meijndert, H. C., Wright, J. R., Fedak, P. W., Beck, P. L., Muruve, D. A., & Duff, H. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.550624 · Cited by 152
“Male C57BL6 mice 10 –12 weeks of age were used for all studies, and Nlrp3 / (n 7) compared with Nlrp3 / (n 8) as described previously (15).”
BackgroundMethodSelf-citationRIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
Chen, H., Fang, Y., Wu, J., Chen, H., Zou, Z., Zhang, X., Shao, J., & Xu, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0936-8 · Cited by 163
The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
Kim, Y. G., Kim, S.-M., Kim, K.-P., Lee, S.-H., & Moon, J.-Y. (2019) · Cells · doi:10.3390/cells8111389 · Cited by 150
“In accordance with animal studies, NLRP3 mRNA was increased in human fibrotic renal diseases and positively correlated with serum creatinine levels [46].”
BackgroundResultInfluentialThe inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?
Kahlenberg, J. M., & Kaplan, M. J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000088 · Cited by 173
“injury [35], so it remains to be determined whether”
BackgroundKomada, T., Chung, H., Lau, A. N., Platnich, J. M., Beck, P. L., Benediktsson, H., Duff, H. J., Jenne, C. N., & Muruve, D. A. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017080863 · Cited by 164
Self-citationDai, X., Liao, R., Liu, C., Liu, S., Huang, H., Liu, J., Jin, T., Guo, H., Zheng, Z., Xia, M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102033 · Cited by 156
Inflammasome-Independent Role of NLRP3 Mediates Mitochondrial Regulation in Renal Injury
Kim, S.-M., Kim, Y. G., Kim, D.-J., Park, S. H., Jeong, K.-H., Lee, Y. H., Lim, S. J., Lee, S.-H., & Moon, J.-Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02563 · Cited by 147
“Both of inflammasome dependent and independent NLRP3 is essential for the renal damage in UUO model (28).”
BackgroundThe key role of NLRP3 and STING in APOL1-associated podocytopathy
Wu, J., Raman, A., Coffey, N. J., Sheng, X., Wahba, J., Seasock, M. J., Ma, Z., Beckerman, P., Laczko, D. I., Palmer, M. B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci136329 · Cited by 151
“STING and the NLRP3 inflammasome have been shown to play a role in tubule cells of the kidney in unilateral ureteral obstruction (49), adenine-induced tubulointerstitial nephritis (50), and remnant kidney (5/6 nephrectomy; ref.”
BackgroundConversion of extracellular ATP into adenosine: a master switch in renal health and disease
Dwyer, K. M., Kishore, B. K., & Robson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0304-7 · Cited by 153
Wang, M., Zhao, J., Zhang, N., & Chen, J. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.025 · Cited by 143
Kim, H. J., Lee, D. W., Ravichandran, K., Keys, D. O., Akçay, A., Nguyen, Q., He, Z., Jani, A. H., Ljubanović, D. G., & Edelstein, C. L. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.205732 · Cited by 143
“A role of the NLRP3 inflammasome was demonstrated in a unilateral ureteric obstruction model of CKD (Vilaysane et al., 2010).”
BackgroundMulay, S. R. (2019) · Kidney International · doi:10.1016/j.kint.2019.01.014 · Cited by 143
Li, J., Lin, Q., Shao, X., Li, S., Zhu, X., Wu, J., Mou, S., Gu, L., Wang, Q., Zhang, M., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05587-5 · Cited by 146
“CKD affects approximately 14.3% of the population worldwide [1–3].”
BackgroundInfluentialCurcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
Lu, M., Yin, N., Liu, W., Cui, X., Chen, S., & Wang, E. (2017) · BioMed Research International · doi:10.1155/2017/1516985 · Cited by 145
“This is because curcumin has been shown to reduce NLRP3 inflammasome activation and IL-1β production in lipopolysaccharideinduced septic shock [29], and both IL-1β (a proinflammatory cytokine) and NLRP3 inflammasomes have been shown to be involved in the development of DN [14, 17].”
BackgroundKim, S., Joe, Y., Jeong, S. O., Zheng, M., Back, S. H., Park, S. W., Ryter, S. W., & Chung, H. T. (2014) · Innate Immunity · doi:10.1177/1753425913508593 · Cited by 132
“Furthermore, the activation of NLRP3 inflammasome increases renal inflammation with up-regulation of IL-1b and IL-8, which leads to chronic kidney disease.(58) Thus, the effects of CO on NLRP3 inflammasome activation were investigated in STZ-treated mice.”
BackgroundLee, H., Fessler, M. B., Qu, P., Heymann, J. A. W., & Kopp, J. B. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01921-7 · Cited by 142
“Blockage of NLRP3 attenuates macrophage infiltration, M1 polarization, decrease in gene expression of connexins, TGF-β, connective tissue growth factor and α-smooth muscle actin, reduction of extracellular matrix deposition, and prevents renal fibrosis and loss of renal function [48, 54, 55].”
BackgroundImmunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Oxalate, inflammasome, and progression of kidney disease
Ermer, T., Eckardt, K., Aronson, P. S., & Knauf, F. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000229 · Cited by 139
Rovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 133
“NLRP3 protein expression rises in parallel to CKD progression in mice, and genetic ablation of Nlrp3 in this murine model of CKD results in the attenuation of tubular injury, reduced leukocyte infiltration, and renal fibrosis (338).”
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Benetti, E., Chiazza, F., Patel, N. S. A., & Collino, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/678627 · Cited by 120
“In a cohort of renal biopsies from patients with nondiabetic kidney disease, levels of mRNA encoding NLRP3 correlate with renal function [58], strongly suggesting thatNLRP3 contributes to the pathogenesis of chronic kidney disease.”
BackgroundPathophysiology of Urinary Tract Obstruction
Gulmi, F. A., & Felsen, D. (2012) · Wiley eBooks · doi:10.1002/9781444345148.ch7 · Cited by 122
Li, S., Lin, Q., Shao, X., Mou, S., Gu, L., Wang, X., Zhang, Z., Shen, J., Zhou, Y., Qi, C., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.07.001 · Cited by 120
Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation
Zhao, J., Zhang, H., Huang, Y., Wang, H., Wang, S., Zhao, C., Liang, Y.-J., & Yang, N. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.05.027 · Cited by 125
Wang, H., Wang, Y., Du, Q., Lü, P., Fan, H., Lu, J., & Hu, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.009 · Cited by 127
Liu, D., Wen, Y., Tang, T., Lv, L., Tang, R., Liu, H., Ma, K., Crowley, S. D., & Liu, B. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662064 · Cited by 121
NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis
Chung, H., Vilaysane, A., Lau, A. N., Stahl, M., Morampudi, V., Bondzi‐Simpson, A., Platnich, J. M., Bracey, N. A., French, M.-C., Beck, P., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.14 · Cited by 116
“Our previous studies have demonstrated reduced epithelial cell apoptosis during tubular injury induced by UUO in Nlrp3− /− mice.(20) To determine whether epithelial cell injury in this model was associated with tubular ASC speck formation, wild-type, Nlrp3− /− and ASC− /− mice under-”
BackgroundMethodSelf-citationEndothelial Damage, Inflammation and Immunity in Chronic Kidney Disease
Díaz‐Ricart, M., Torramadé‐Moix, S., Pascual, G., Palomo, M., Moreno‐Castaño, A. B., Martínez-Sánchez, J., Vera, M., Cases, A., & Escolar, G. (2020) · Toxins · doi:10.3390/toxins12060361 · Cited by 124
Fang, L., Xie, D., Wu, X., Cao, H., Su, W., & Yang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072344 · Cited by 115
Protective effects of sirtuin 3 in a murine model of sepsis-induced acute kidney injury
Zhao, W.-Y., Zhang, L., Sui, M.-X., Zhu, Y.-H., & Zeng, L. (2016) · Scientific Reports · doi:10.1038/srep33201 · Cited by 114
Solini, A., Menini, S., Rossi, C., Ricci, C., Santini, E., Blasetti Fantauzzi, C., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 107
“A previous report in the UUO model showed that both the haematopoietic and the non-haematopoietic cellular compartments participate in renal NLRP3 activation [27].”
BackgroundResultInfluentialAlvarenga, L., Salarolli, R., Cardozo, L., SANTOS, R. W. D., de Brito, J. S., Kemp, J. A., Reis, D. C. M. V., Paiva, B. R., Stenvinkel, P., Lindholm, B., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.03.007 · Cited by 116
Liu, D., Xu, M., Ding, L., Lv, L., Liu, H., Ma, K., Zhang, A., Crowley, S. D., & Liu, B. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.09.018 · Cited by 111
The emerging role of the inflammasome in kidney diseases
Chang, A., Ko, K., & Clark, M. R. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000444814.49755.90 · Cited by 110
“[14] observed that NLRP3 deficiency abrogated the magnitude of kidney injury in mice.”
BackgroundRenal immune surveillance and dipeptidase-1 contribute to contrast-induced acute kidney injury
Lau, A. N., Chung, H., Komada, T., Platnich, J. M., Sandall, C. F., Choudhury, S. R., Chun, J., Naumenko, V., Surewaard, B. G. J., Nelson, M. C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96640 · Cited by 112
Self-citationImmunometabolic rewiring of tubular epithelial cells in kidney disease
van der Rijt, S., Leemans, J. C., Florquin, S., Houtkooper, R. H., & Tammaro, A. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00592-x · Cited by 110
Malik, A. F., Hoque, R., Ouyang, X., Ghani, A., Hong, E., Khan, K., Moore, L. B., Ng, G., Munro, F., Flavell, R. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105152108 · Cited by 107
Mason, D. R., Beck, P. L., & Muruve, D. A. (2012) · Journal of Innate Immunity · doi:10.1159/000334247 · Cited by 105
Self-citationBetaine supplementation protects against high-fructose-induced renal injury in rats
Fan, C., Wang, M., Ge, C., Wang, X., Li, J., & Kong, L. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.010 · Cited by 108
“The importance of renal inflammation promoted by the NLRP3 inflammasome activation as a sensor for metabolic stress has been further highlighted in chronic kidney disease [21,22].”
BackgroundChen, Z., Jin, S., Wang, M., Jin, X., Lv, C., Deng, Y., & Wang, J. (2014) · The Anatomical Record · doi:10.1002/ar.23059 · Cited by 102
“It has also been reported that NLRP3mediated IL-1b production contributes to the progres- sion of chronic kidney disease (Vilaysane et al., 2010).”
BackgroundLiu, J. J., Berthier, C. C., & Kahlenberg, J. M. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40166 · Cited by 106
Zhou, X., Ji, S., Chen, L., Liu, X., Deng, Y., You, Y., Wang, M., He, Q., Peng, B., Yang, Y., et al. (2024) · Microbiome · doi:10.1186/s40168-024-01826-9 · Cited by 103
“Notably, nod-like receptor protein 3 (NLRP3), an inflammatory regulator, has been found to be activated in mouse models of CKD and AKI, as well as in human kidney diseases [20–22].”
BackgroundNLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients
Granata, S., Masola, V., Zoratti, E., Scupoli, M. T., Baruzzi, A., Messa, M., Sallustio, F., Gesualdo, L., Lupo, A., & Zaza, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122272 · Cited by 103
“Inhibitory effects of mitoTEMPO on caspase-1 activation and maturation of IL-1β and IL-18 induced by LPS/ATP in PBMC from CKD-HD To better assess the role of mitochondria in inflammasome activation, we measured the level of CASP-1, IL-1β and IL-18 in PBMC from CKD-HD stimulated with LPS/ATP, Pathogen- doi:10.1371/jour…”
BackgroundInfluentialDendritic Cells and Macrophages: Sentinels in the Kidney
Weisheit, C. K., Engel, D. R., & Kurts, C. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07100714 · Cited by 115
“Experimental studies have also shown a role of the inflammasome in IRI (90) and unilateral ureter ligation (91).”
Background
Metadata
- Authors
- Vilaysane, A., Chun, J., Seamone, M. E., Wang, W., Chin, R., Hirota, S., Li, Y., Clark, S. A., Tschopp, J., Trpkov, K., Hemmelgarn, B. R., Beck, P. L., & Muruve, D. A.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Vilaysane, Akosua
- Chun, Justin
- Seamone, Mark E.
- Wang, Wenjie
- Chin, Rick
- Hirota, Simon
- Li, Yan
- Clark, Sharon A.
- Hemmelgarn, Brenda R.
- Beck, Paul L.
- Muruve, Daniel A.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-10
- Volume
- 21
- Issue
- 10
- Pages
- 1732-1744
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3013544
- OpenAlex
- W2111994713
- Cited by
- 587
- References
- 44
- Citations by year
- 2026: 30 · 2025: 44 · 2024: 48 · 2023: 40 · 2022: 50 · 2021: 42 · 2020: 43 · 2019: 42 · 2018: 46 · 2017: 36 · 2016: 44 · 2015: 29 · 2014: 36 · 2013: 26 · 2012: 16
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- NLRP3 inflammasome, chronic kidney disease, renal inflammation, caspase-1, IL-1β, IL-18, unilateral ureteral obstruction, renal tubular injury, renal fibrosis, non-diabetic kidney disease, therapeutic target
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cells, Cultured, Fibrosis, Humans, Kidney, Male, Mice, Inbred C57BL, Nephritis, RNA, Messenger, Ureteral Obstruction, Mice, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.